Lunit and Summit to evaluate pathology platform for tumour analysis
Lunit will examine haematoxylin and eosin-stained whole-slide images to profile tumour microenvironment characteristics.
Drug Development
Pathos AI completes $237m Series E round to expand oncology pipeline
Boehringer and Microsoft collaborate to explore AI in clinical research
Celltrion and Kaigene sign $580m licence deal for KG013
Astellas and AI Proteins sign miniprotein therapeutics deal
MSD’s Keytruda and Padcev combination receives EC approval
FDA approves Cosette’s Evoxac oral solution for Sjögren’s disease
Sanofi and ScionxBio partner on mRNA therapies
